Huster et al., 2006 - Google Patents
Unidirectional development of CD8+ central memory T cells into protective Listeria‐specific effector memory T cellsHuster et al., 2006
View PDF- Document ID
- 4887906130388811486
- Author
- Huster K
- Koffler M
- Stemberger C
- Schiemann M
- Wagner H
- Busch D
- Publication year
- Publication venue
- European journal of immunology
External Links
Snippet
Three distinct subsets of antigen‐experienced CD8+ T cells have been identified so far: short‐living effector T cells (TEC) and two long‐living subsets, described as central (TCM) and effector memory (TEM) T cells. The lineage relationships of these subpopulations as …
- 210000003071 memory T lymphocyte 0 title description 27
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0636—T lymphocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Huster et al. | Unidirectional development of CD8+ central memory T cells into protective Listeria‐specific effector memory T cells | |
Corbin et al. | Duration of infection and antigen display have minimal influence on the kinetics of the CD4+ T cell response to Listeria monocytogenes infection | |
US20230145991A1 (en) | T cell compositions for immunotherapy | |
Tay et al. | CD40L expression allows CD8+ T cells to promote their own expansion and differentiation through dendritic cells | |
Klenerman | The (gradual) rise of memory inflation | |
MacLeod et al. | Memory CD4 T cells: generation, reactivation and re‐assignment | |
Ho et al. | In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naive repertoire | |
Obar et al. | Memory CD8+ T cell differentiation | |
Bourgeois et al. | CD8 lethargy in the absence of CD4 help | |
Linton et al. | Intrinsic versus environmental influences on T‐cell responses in aging | |
Bachmann et al. | Long‐lived memory CD8+ T cells are programmed by prolonged antigen exposure and low levels of cellular activation | |
Stemberger et al. | Stem cell-like plasticity of naive and distinct memory CD8+ T cell subsets | |
Seddiki et al. | Human antigen‐specific CD4+ CD25+ CD134+ CD39+ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses | |
Jelley-Gibbs et al. | Repeated stimulation of CD4 effector T cells can limit their protective function | |
Monsurrò et al. | Functional heterogeneity of vaccine-induced CD8+ T cells | |
Bachmann et al. | Maintenance of memory CTL responses by T helper cells and CD40‐CD40 ligand: antibodies provide the key | |
Kallies | Distinct regulation of effector and memory T‐cell differentiation | |
Ashok et al. | Cross‐presenting dendritic cells are required for control of L eishmania major infection | |
Bandaru et al. | Phosphorylated STAT3 and PD‐1 regulate IL‐17 production and IL‐23 receptor expression in Mycobacterium tuberculosis infection | |
JP2022087340A (en) | Generation and use in adoptive immunotherapy of stem cell-like memory t cells | |
Flores‐Langarica et al. | T‐zone localized monocyte‐derived dendritic cells promote Th1 priming to Salmonella | |
Ahmadi et al. | CD40 Ligand‐activated, antigen‐specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I‐and class II‐binding peptides | |
Stemberger et al. | Origin of CD8+ effector and memory T cell subsets | |
Jordan et al. | Kinetics and phenotype of vaccine-induced CD8+ T-cell responses to Toxoplasma gondii | |
Imai et al. | Tumor progression inhibits the induction of multifunctionality in adoptively transferred tumor‐specific CD8+ T cells |